Analysis of Aurora B kinase in non-Hodgkin lymphoma (Q39788234)

14 September 2017

Analysis of Aurora B kinase in non-Hodgkin lymphoma (English)

1 reference

14 September 2017

Takayuki Ikezoe

1

1 reference

14 September 2017

Tamotsu Takeuchi

2

1 reference

14 September 2017

Jing Yang

3

1 reference

14 September 2017

Yoshihiro Adachi

4

1 reference

14 September 2017

Chie Nishioka

5

1 reference

14 September 2017

Mutsuo Furihata

6

1 reference

14 September 2017

H Phillip Koeffler

7

1 reference

14 September 2017

Akihito Yokoyama

8

1 reference

14 September 2017

12 October 2009

1 reference

14 September 2017

Laboratory Investigation

1 reference

14 September 2017

89

1 reference

14 September 2017

12

1 reference

14 September 2017

1364-1373

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2009.106

14 September 2017

0 references

cites work

The cellular geography of aurora kinases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Aurora-A - a guardian of poles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Identification and characterization of STK12/Aik2: a human gene related to aurora of Drosophila and yeast IPL1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Dynamic localization and functional implications of Aurora-C kinase during male mouse meiosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

The EphA4 and EphB1 receptor tyrosine kinases and ephrin-B2 ligand regulate targeted migration of branchial neural crest cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Targeting polo-like kinase 1 for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Expression of PLK1 and survivin in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Expression of Polo-Like Kinase (PLK1) in non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

7 January 2021

A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

7 January 2021

Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

7 January 2021

PC-SPES: a potent inhibitor of nuclear factor-kappa B rescues mice from lipopolysaccharide-induced septic shock

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

7 January 2021

Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.106

7 January 2021

10.1038/LABINVEST.2009.106

Identifiers

DOI

1 reference

14 September 2017

1 reference